Trial Profile
Tadalafil (5 mg/day or 20mg on-demand) in men with incontinence following bilateral nerve-sparing robot-assissted radical prostatectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- 04 Mar 2012 New trial record
- 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.